ROXADUSTAT GRANTED ORPHAN DRUG DESIGNATION FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES BY THE U.S. FOOD AND DRUG ADMINISTRATION

Reuters · 1d ago

Please log in to view news